Monsanto Co. (NYSE:MON) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued on Wednesday.

A number of other research analysts have also weighed in on MON. TheStreet raised Monsanto to a “buy” rating in a report on Thursday, May 26th. Deutsche Bank AG reaffirmed a “buy” rating and set a $100.00 target price on shares of Monsanto in a report on Wednesday, June 1st. Vetr lowered Monsanto from a “strong-buy” rating to a “buy” rating and set a $117.33 target price for the company. in a report on Monday, May 30th. Sanford C. Bernstein reaffirmed a “sell” rating on shares of Monsanto in a report on Sunday, May 29th. Finally, S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $111.12.

Analyst Recommendations for Monsanto (NYSE:MON)

Monsanto (NYSE:MON) opened at 102.88 on Wednesday. Monsanto has a 1-year low of $81.22 and a 1-year high of $114.26. The firm has a market cap of $45.02 billion, a P/E ratio of 45.28 and a beta of 1.24. The stock has a 50 day moving average price of $105.86 and a 200 day moving average price of $100.40.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/monsanto-co-mon-stock-rating-upgraded-by-jpmorgan-chase-co.html

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.40 by $0.23. The company had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.49 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The firm’s quarterly revenue was down 8.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.39 EPS. On average, analysts anticipate that Monsanto will post $4.46 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.10%. Monsanto’s dividend payout ratio (DPR) is presently 89.26%.

In other news, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.

A number of large investors have recently modified their holdings of MON. Vanguard Group Inc. boosted its stake in shares of Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock valued at $3,146,826,000 after buying an additional 389,914 shares during the last quarter. State Street Corp boosted its stake in shares of Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock valued at $1,634,002,000 after buying an additional 173,201 shares during the last quarter. FMR LLC boosted its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock valued at $1,540,185,000 after buying an additional 38,316 shares during the last quarter. Finally, Capital International Investors boosted its stake in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock valued at $846,690,000 after buying an additional 476,848 shares during the last quarter. 79.06% of the stock is currently owned by institutional investors.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.